About the Authors

Holly G. Prigerson

Holly_Prigerson@dfci.harvard.edu

Affiliations Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Center for Psycho-Oncology and Palliative Care Research, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America, Harvard Medical School Center for Palliative Care, Boston, Massachusetts, United States of America

Mardi J. Horowitz

Affiliation Department of Psychiatry, University of California School of Medicine, San Francisco, California, United States of America

Selby C. Jacobs

Affiliation Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, United States of America

Colin M. Parkes

Affiliation St. Christopher's Hospice, Sydenham, and St. Joseph's Hospice, Hackney, England

Mihaela Aslan

Affiliation Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America

Karl Goodkin

Affiliations Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, California, United States of America, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, United States of America

Beverley Raphael

Affiliation Department of Population Mental Health and Disasters, University of Western Sydney Medical School, New South Wales, Australia

Samuel J. Marwit

Affiliation Department of Psychology, University of Missouri, St. Louis, Missouri, United States of America

Camille Wortman

Affiliation Department of Psychology, State University of New York at Stony Brook, New York, United States of America

Robert A. Neimeyer

Affiliation Department of Psychology, The University of Memphis, Memphis, Tennessee, United States of America

George Bonanno

Affiliation Department of Counseling and Clinical Psychology, Teachers College, Columbia University, New York, New York, United States of America

Susan D. Block

Affiliations Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Center for Psycho-Oncology and Palliative Care Research, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America, Harvard Medical School Center for Palliative Care, Boston, Massachusetts, United States of America

David Kissane

Affiliation Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

Paul Boelen

Affiliation Department of Clinical and Health Psychology, Utrecht University, Utrecht, The Netherlands

Andreas Maercker

Affiliation Department of Clinical Psychology, University of Zürich, Zürich, Switzerland

Brett T. Litz

Affiliations Veterans Affairs Boston Healthcare System, Boston, Massachusetts, United States of America, National Center for PTSD, Boston, Massachusetts, United States of America, Boston University School of Medicine, Boston, Massachusetts, United States of America

Jeffrey G. Johnson

Affiliation Department of Psychiatry, Columbia University, New York, New York, United States of America

Michael B. First

Affiliation Department of Psychiatry, Columbia University, New York, New York, United States of America

Paul K. Maciejewski

Affiliations Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Center for Psycho-Oncology and Palliative Care Research, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

Competing Interests

MBF received consultant fees over the past 5 years from Roche, Corcept, Wyeth, Cephalon, Astra-Zeneca, Shire, GSK, and Eli Lilly for preparing diagnostic interviews and/or conducting diagnostic trainings at investigator meetings.

Author Contributions

ICMJE criteria for authorship read and met: HGP MJH SCJ CMP MA BR SJM CW KG RAN GB SDB DK PB AM BL JGJ MF PKM. Agree with the manuscript's results and conclusions: HGP MJH SCJ CMP MA BR SJM CW KG RAN GB SDB DK PB AM BL JGJ MF PKM. Designed the experiments/the study: HGP MJH PKM. Analyzed the data: PKM HGP MA. Collected data/did experiments for the study: HGP PKM. Enrolled patients: HGP. Wrote the first draft of the paper: HGP PKM. Contributed to the writing of the paper: HGP MJH SCJ CMP BR SJM CW RAN GB SDB DK PB AM JGJ MF PKM. Contributed to the conceptualisation: BR. Contributed items to the scale to assess PGD: CW. Assisted with interpretation of the results and contributed to the writing of the final manuscript, and reviewed and approved the contributions of others: RAN.